They sue me because the medicine is illegal, but if it is legal, they say I can't afford it?

Chapter 260 Share Exchange?



Chapter 260 Share Exchange?

……

There are many speculations from the outside world.

It has no effect on Chen Xuan's mood for eating.

Anna wanted to speak several times, but seeing how deliciously he was eating, she felt too embarrassed to speak.

Although she is a foreigner,

But I also know what Lao Tzu said - Don’t talk when you sleep, and don’t talk when you eat!

Talking about work when you are enjoying your meal will indeed make people feel annoyed and affect your mood for eating.

That's why she was too embarrassed to speak and could only wait for him to eat first.

However, this food stall also felt extremely novel to her.

It was her first time eating at a food stall, and the experience was very interesting. Especially when she saw Chen Xuan eating so happily, her appetite inexplicably improved.

I wonder if it’s because of the novelty?

Anna found that she quite liked the taste here. It seemed to taste better than those in high-end restaurants.

She even followed Chen Xuan's example and asked for a bowl of rice to go with it.

In an instant, it felt even better.

Which tastes better, food stalls or high-end restaurants?

This is a very controversial topic.

No one can tell which one is better.

Because people who eat at high-end restaurants rarely come to eat at food stalls.

But if you experience it once in a while, you will really feel it is very fresh and fall in love with the taste.

But eating it occasionally and eating it frequently are two completely different experiences.

Maybe after a few times, you will develop a resistance to food stalls.

"You came to China this time."

"It's not just as simple as asking me to treat you to a food stall, right?"

"If you have anything to say, you can tell me now and I can think about it."

After finishing the meal, Chen Xuan took the initiative to get to the point.

Eating is very important. Wait until you are full before doing anything else.

This way it won't affect your mood for eating. No matter what happens later, at least you can eat first.

When the meal is almost finished, it is the best time to talk about business.

"Mr. Chen."

"We at Novartis would really like to work with you again."

"I wonder if you're interested this time?"

Hearing Chen Xuan's words, Anna smiled slightly, then wiped her mouth with a tissue and asked directly.

She is very busy at work, and she came to China in person this time because this matter is very important.

If it weren't for this cooperation, she wouldn't have waited in China for several days in a row.

"How do you want to cooperate?" Chen Xuanrou asked with interest.

After Changfeng Group and AbbVie made their offers,

He was curious about what price Novartis could offer.

"Originally, we intended to use 300 billion to acquire your new drug patent." Anna said with a smile.

Before coming to Hua Xia, she had held several meetings with Novartis executives and the board of directors.

The reserve price would be raised higher and higher with each meeting, especially as Changfeng Group and AbbVie made bids one after another, forcing them to raise the reserve price again and again.

In addition, over the past period of time, the clinical trial data of lung cancer-specific drugs have been getting better and better.

The first phase of clinical trials is now nearing completion, and so far no problems have been found in the drug trials.

The performance of the drug in all aspects has exceeded the initial expectations. It can be basically confirmed that there is no problem with the drug. This is a very mature drug, which can be seen from its various manifestations.

It is also because the performance of clinical trials is getting better and better that Novartis will gradually raise the bottom price.

With the current performance,

All Novartis executives know that it is basically impossible to get the formula without paying a high price.

The advantages of the lung cancer drug are now so great that it is even higher than when AbbVie offered the bid, so it is impossible to get it at this price.

Taking several factors into consideration, Novartis executives unanimously approved the 300 billion yuan offer. They all felt that the lung cancer drug was worth this price.

Hearing this, Chen Xuan did not speak, but waited for Anna to continue.

Since Anna said "originally", it proves that the 300 billion yuan offer is not the final decision, and there should be a latest plan.

And he was not wrong, Anna continued speaking.

"Then I discovered you weren't very interested in selling the new drug formula."

"In other words, even if we offer 300 billion, we still won't be able to impress you."

“So, I discussed it with other Novartis executives and eventually came up with a new plan.”

Anna paused here.

Obviously, she wanted to see Chen Xuan's reaction.

"Oh? Tell me about it." Chen Xuan became a little interested.

He was very curious about what option would be better than a 300 billion acquisition?

"I hope to achieve cooperation between the two sides through equity exchange."

"Novartis is exchanging 3% of its shares for 60% of Antai Pharmaceutical Group's shares."

Anna said directly, "I wonder if Mr. Chen is interested in this kind of cooperation plan? We can discuss the specific details slowly."

This plan was also something she suddenly thought of after coming to China.

It would probably be difficult to get Chen Xuan to agree to directly purchase the formula of the lung cancer drug, so this is the only roundabout solution he could think of.

If Novartis can control the shares of Antai Pharmaceutical Group, it will be equivalent to controlling the patent for the lung cancer drug.

In particular, the 60% stake makes Antai Pharmaceutical Group equivalent to a subsidiary of Novartis, which is no longer a difference.

Hearing this, Chen Xuan found it a bit interesting.

I have to say that this plan is very thoughtful and sincere.

After Novartis acquired the formula for a special liver cancer drug, its stock price has been rising steadily, and its market value has now exceeded US$200 billion.

In other words, 3% of Novartis' shares are worth more than 60 billion US dollars, which is almost 420 billion RMB!

At a price of 420 billion yuan, it only acquired 60% of the shares of Antai Pharmaceutical Group. Compared with Antai Group, its valuation has reached 700 billion yuan.

In contrast, Changfeng Group wants to use 120 billion to acquire 60% of the shares of Antai Pharmaceutical Group.

And AbbVie only offered 320 billion, but wanted the complete formula of lung cancer medicine and 60% of the shares.

Novartis directly offered shares worth 420 billion yuan, while only 60% of Antai Pharmaceutical Group's shares are required. There is a huge difference.

In comparison, Novartis' sincerity appears to be greater.

Of course, Anna only gave such a premium because of Chen Xuan's potential. If it weren't for him, Novartis would never have offered such a price for a formula.

There is such potential for a specific drug for lung cancer, but this potential is empty until it passes clinical trials.

If it can pass clinical trials and be approved for marketing, not to mention 500 billion, even 1000 billion is possible.

But before that, any valuation is a risky investment, and the high or low valuation affects the level of investment risk.

Therefore, Anna focused more on Chen Xuan's potential, betting that he could develop new special medicines in the future.

For this reason, after the equity exchange, the agreement must also contain provisions, such as stipulating that he must stay in Antai Pharmaceutical Group for a long time and continue to develop new drugs for the company in the future.

Provisions like this will definitely appear in the equity exchange agreement, and the bet is on his future new achievements, not just a drug.

Of course, if he can develop new drugs, Novartis will definitely provide new subsidies. It is impossible for him to work for the company in vain. This is another new agreement.

But it doesn't matter what.

Anna was able to come up with this kind of cooperation plan.

First, he is optimistic about the future rights of the special medicine for lung cancer, and second, he is very optimistic about the value of Chen Xuan as a person.

She wants both, so she can achieve this through equity exchange. This is the best and most sincere option.

……


Tip: You can use left, right, A and D keyboard keys to browse between chapters.